Dr. Setia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-834-7644
Education & Training
- UMass Chan - BaystateFellowship, Cytopathology, 2012 - 2013
- Lady Hardinge Medical CollegeClass of 2003
- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Gastrointestinal Pathology
Certifications & Licensure
- IL State Medical License 2015 - 2026
- MA State Medical License 2012 - 2017
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma.Gertruda Evaristo, Carla Harmath, Jeremy P Segal, Ardaman Shergill, Namrata Setia
Cancer Reports. 2024-12-01 - MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy.Rushabh Gujarathi, Sara Abou Azar, Joseph Tobias, Blase N Polite, Namrata Setia
Endocrine-Related Cancer. 2024-11-01 - High risk features in colorectal adenomatous polyps: A multi-institutional study.Michael Lee, Huaibin Mabel Ko, Satoru Kudose, Helen Remotti, Won-Tak Choi
Annals of Diagnostic Pathology. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: